Latest Financial Updates

Read latest financial news update from our blog

Worldview: Warren Buffett steps down as Berkshire CEO, citing age and confidence in successor Greg Abel
Worldview: Warren Buffett steps down as Berkshire CEO, citing age and confidence in successor Greg Abel

Sign up for your early morning brew of the BizNews Insider to keep you up to speed with th...

Admin | Finance | 2 weeks ago

Cytokinetics Inc (CYTK) Unveils New Data on Aficamten's Efficacy in HCM Patients | CYTK stock news
Cytokinetics Inc (CYTK) Unveils New Data on Aficamten's Efficacy in HCM Patients | CYTK stock news

Summary Cytokinetics Inc (CYTK, Financial) has released new data from the SEQUOIA-HCM tri...

Admin | Finance | 2 weeks ago

TalentHQ Launches AI Interviewer to Streamline Candidate Sourcing
TalentHQ Launches AI Interviewer to Streamline Candidate Sourcing

TalentHQ unveils its AI-powered interview platform, helping companies screen candidates fa...

Admin | Finance | 2 weeks ago

Indian filmmakers 'push dumbness': Ram Gopal Varma makes shocking comparison to Hollywood as he reviews 'Mission: Impossible'
Indian filmmakers 'push dumbness': Ram Gopal Varma makes shocking comparison to Hollywood as he reviews 'Mission: Impossible'

‘We Assume the Audience to Be Dumb’ — RGVzoomin (@RGVzoomin) Social Media Reacts to Varm...

Admin | Finance | 2 weeks ago

Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peri
Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peri

Intellia Therapeutics (NTLA, Financial) showcased a 90% reduction in serum TTR maintained...

Admin | Finance | 2 weeks ago

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci

Applied Therapeutics (APLT, Financial) reveals mixed results from the INSPIRE Phase 2/3 tr...

Admin | Finance | 2 weeks ago

SEDCO Capital REIT dips to all-time low
SEDCO Capital REIT dips to all-time low

Tadawul trading screen Units of TASI-listed SEDCO Capital REIT Fund declined to their low...

Admin | Finance | 2 weeks ago

My son and daughter are 9 years apart, and I worried their age gap would ruin their relationship. But they became true friends.
My son and daughter are 9 years apart, and I worried their age gap would ruin their relationship. But they became true friends.

This story is available exclusively to Business Insider subscribers. Become an Insider and...

Admin | Finance | 2 weeks ago

Join Our Newsletter

join our newsletter to receive update from us